The present invention provides tromethamine salt of (Z)-7-[3,5-Dihydroxy-2-((E)-3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid in crystalline Form 1 and amorphous form. This compound is may also be referred to as "tromethamine salt of bimatoprost acid." The invention crystalline form is useful for solid ocular implant or topical formulations, utilized in the treatment of various ocular conditions, such as, for example, ocular hypertension.
本发明提供了晶体形式1和非晶态形式的(Z)-7-[3,5-二羟基-2-((E)-3-羟基-5-苯基-戊-1-烯基)-环戊基]-庚-5-烯酸的醇胺盐。该化合物也可以称为“贝马
特普罗斯特酸的醇胺盐”。本发明的晶体形式可用于固体眼内植入物或局部制剂,用于治疗各种眼部疾病,例如眼压增高。